Naringin, a natural dietary compound, prevents intestinal tumorigenesis in ApcMin/+ mouse model
Naringin, a natural dietary compound, prevents intestinal tumorigenesis in ApcMin/+ mouse model
复制标题
DOI:
10.1007/s00432-015-2097-9
复制
发表时间:
2016-05
影响因子:
3.6
通讯作者:
Yu-sheng Zhang;Ye Li;Yan Wang;Shi-Yue Sun;Tao Jiang;Cong Li;S. Cui;Xian-Jun Qu
中科院分区:
文献类型:
--
作者:
Yu-sheng Zhang;Ye Li;Yan Wang;Shi-Yue Sun;Tao Jiang;Cong Li;S. Cui;Xian-Jun Qu
PurposeNaringin is a natural dietary flavonoid compound. We aimed to evaluate the effects of naringin on intestinal tumorigenesis in the adenomatous polyposis coli multiple intestinal neoplasia (ApcMin/+) mouse model.MethodsApcMin/+mice were given either naringin (150 mg/kg) or vehicle by p.o. gavage daily for 12 consecutive weeks. Mice were killed with ether, and blood samples were collected to assess the concentrations of IL-6 and PGE2. Total intestines were removed, and the number of polyps was examined. Tissue samples of intestinal polyps were subjected to the assays of histopathology, immunohistochemical analysis and Western blotting analysis.ResultsApcMin/+mice fed with naringin developed less and smaller polyps in total intestines. Naringin prevented intestinal tumorigenesis without adverse effects. Histopathologic analysis revealed the reduction of dysplastic cells and dysplasia in the adenomatous polyps. The treatments’ effects might arise from its anti-proliferation, induction of apoptosis and modulation of GSK-3β and APC/β-catenin signaling pathways. Naringin also exerted its effects on tumorigenesis through anti-chronic inflammation.ConclusionNaringin prevented intestinal tumorigenesis likely through a collection of activities including anti-proliferation, induction of apoptosis, modulation of GSK-3β and APC/β-catenin pathways and anti-inflammation. Naringin is a potential chemopreventive agent for reducing the risk of colonic cancers.